Market Access Monthly | Edition #5

Unlock exclusive insights with Market Access Monthly, which delivers MMIT's latest thought leadership straight to your LinkedIn notifications and inbox. Click the links below for free thought leadership from our experts. 

Harnessing Lab Data to Speed Time to Treatment

Lab data is often the key driver in diagnostic and therapeutic decisions, which makes it especially valuable for manufacturers. Learn how we build clinical profiles to meet client needs for patient and provider identification. https://hubs.ly/Q031YpQQ0

Payer Response to the Great Medicaid Unwinding

Large-scale, ongoing channel enrollment shifts can significantly impact a brand’s payer mix and patient utilization, while having negative impacts on medication adherence and continuity of care. https://hubs.ly/Q031YqtF0

Accessing Weight-Loss GLP-1s: The Role of Compounding Pharmacies 

As patients struggle with the high cost and limited availability of commercial GLP-1s, many have turned to compounding pharmacies. How is the industry responding to safety concerns? https://hubs.ly/Q031YqR-0

Smoothing Patient Access in Rare Disease

This case study tells how one small biopharma company leveraged MMIT's coverage data to prioritize payer discussions, understand the rationale behind restrictions, and refine its payer/HCP messaging. https://hubs.ly/Q031YrQX0

Planning for Growth with Directory of Health Plans

In this case study, learn how a national payer uses MMIT’s real-time enrollment data to track market share, understand the depth and breadth of competitor offerings, and identify new opportunities for expansion. https://hubs.ly/Q031Ys3n0